Launching a Second Scientific Revolution

Key Points:

• The scientific revolution was founded on rejecting central scientific authority, but today a small group of officials and editors hold disproportionate power over scientific truth, as seen during the Covid-19 pandemic restrictions.
• The National Institutes of Health (NIH) has been instrumental in major biomedical advances, including treatments for heart disease, cancer, rheumatoid arthritis, cystic fibrosis, and sickle cell anemia, but it has recently failed to improve U.S. life expectancy despite large investments.
• Science today faces three critical problems: the replication crisis where many studies cannot be reproduced, scientific stagnation with diminishing returns on research investment, and funding concentration in a few institutions limiting opportunities for innovative scientists nationwide.
• To address these issues, the NIH plans to fund replication studies, introduce a replication indicator in PubMed, prioritize funding for cutting-edge and high-risk ideas through a new Unified Funding Strategy, and decouple research funding from institutional facilities support to broaden competition.
• These reforms aim to restore public trust, accelerate biomedical breakthroughs, and democratize scientific funding, effectively launching a "second scientific revolution" focused on replicable, innovative, and widely supported research.